Joseph Michael Fitzgerald

EVP & Group Pres, Cardiology

Joseph Michael Fitzgerald (EVP & Group Pres, Cardiology) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Boston Scientific Corporation (BSX). The largest single filing was $5.0M of BSX (50,000 sh across 3 lots, as filed), executed Nov 3 2025.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 2 sells

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$9.9M

shares × price, as filed

Last traded

Nov 3 2025

Filed Nov 4 2025

Median ADV $938.4M across their filed names

Open performance→

Volume by month

Buys $0 Sells $42.8M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 2 filings

Sector per market data · by filing · past 12 months

Most traded names

BSX

Boston Scientific Corporation BSX · 0 buys · 7 sells 7 filings

Recent filings

BSXSALE Boston Scientific Corporation View filing → $5.0M
50,000 sh across 3 lots
Exec Nov 3 2025
Filed Nov 4 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $4.9M
50,000 sh across 2 lots
Exec Oct 1 2025
Filed Oct 1 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $5.3M
50,000 sh across 2 lots
Exec Sep 2 2025
Filed Sep 3 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $5.2M
50,000 sh × $104.63
Exec Aug 1 2025
Filed Aug 4 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $5.3M
50,000 sh × $106.97
Exec Jul 1 2025
Filed Jul 2 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $5.8M
56,372 sh × $102.88
Exec Jun 4 2025
Filed Jun 4 2025 · 5:30 PM ET BSXSALE Boston Scientific Corporation View filing → $11.3M
132,527 sh × $85.00
Exec Oct 7 2024
Filed Oct 8 2024 · 5:30 PM ET